Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda Article Swipe
Reuben Kiggundu
,
Rachel Wittenauer
,
JP Waswa
,
Hilma Nakambale
,
Freddy Eric Kitutu
,
Marion Murungi
,
Neville Okuna
,
Morries Seru
,
Lynn Lieberman Lawry
,
Mohan P. Joshi
,
Andy Stergachis
,
Niranjan Konduri
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.3390/antibiotics11020199
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.3390/antibiotics11020199
Standardized monitoring of antibiotic use underpins the effective implementation of antimicrobial stewardship interventions in combatting antimicrobial resistance (AMR). To date, few studies have assessed antibiotic use in hospitals in Uganda to identify gaps that require intervention. This study applied the World Health Organization’s standardized point prevalence survey methodology to assess antibiotic use in 13 public and private not-for-profit hospitals across the country. Data for 1077 patients and 1387 prescriptions were collected between December 2020 and April 2021 and analyzed to understand the characteristics of antibiotic use and the prevalence of the types of antibiotics to assess compliance with Uganda Clinical Guidelines; and classify antibiotics according to the WHO Access, Watch, and Reserve classification. This study found that 74% of patients were on one or more antibiotics. Compliance with Uganda Clinical Guidelines was low (30%); Watch-classified antibiotics were used to a high degree (44% of prescriptions), mainly driven by the wide use of ceftriaxone, which was the most frequently used antibiotic (37% of prescriptions). The results of this study identify key areas for the improvement of antimicrobial stewardship in Uganda and are important benchmarks for future evaluations.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/antibiotics11020199
- https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688
- OA Status
- gold
- Cited By
- 72
- References
- 56
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4210586058
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4210586058Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/antibiotics11020199Digital Object Identifier
- Title
-
Point Prevalence Survey of Antibiotic Use across 13 Hospitals in UgandaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-02-04Full publication date if available
- Authors
-
Reuben Kiggundu, Rachel Wittenauer, JP Waswa, Hilma Nakambale, Freddy Eric Kitutu, Marion Murungi, Neville Okuna, Morries Seru, Lynn Lieberman Lawry, Mohan P. Joshi, Andy Stergachis, Niranjan KonduriList of authors in order
- Landing page
-
https://doi.org/10.3390/antibiotics11020199Publisher landing page
- PDF URL
-
https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688Direct OA link when available
- Concepts
-
Antimicrobial stewardship, Medicine, Medical prescription, Antibiotics, Antibiotic resistance, Psychological intervention, Environmental health, Public health, Family medicine, Pharmacy, Intensive care medicine, Nursing, Biology, MicrobiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
72Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 15, 2024: 28, 2023: 20, 2022: 9Per-year citation counts (last 5 years)
- References (count)
-
56Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4210586058 |
|---|---|
| doi | https://doi.org/10.3390/antibiotics11020199 |
| ids.doi | https://doi.org/10.3390/antibiotics11020199 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35203802 |
| ids.openalex | https://openalex.org/W4210586058 |
| fwci | 13.73549185 |
| type | article |
| title | Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda |
| biblio.issue | 2 |
| biblio.volume | 11 |
| biblio.last_page | 199 |
| biblio.first_page | 199 |
| grants[0].funder | https://openalex.org/F4320306115 |
| grants[0].award_id | 7200AA18C00074 |
| grants[0].funder_display_name | United States Agency for International Development |
| topics[0].id | https://openalex.org/T10897 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2402 |
| topics[0].subfield.display_name | Applied Microbiology and Biotechnology |
| topics[0].display_name | Antibiotic Use and Resistance |
| topics[1].id | https://openalex.org/T10209 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9976000189781189 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2735 |
| topics[1].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[1].display_name | Global Maternal and Child Health |
| topics[2].id | https://openalex.org/T10496 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9783999919891357 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2717 |
| topics[2].subfield.display_name | Geriatrics and Gerontology |
| topics[2].display_name | Pharmaceutical Practices and Patient Outcomes |
| funders[0].id | https://openalex.org/F4320306115 |
| funders[0].ror | https://ror.org/01n6e6j62 |
| funders[0].display_name | United States Agency for International Development |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2165 |
| apc_paid.value | 2000 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2165 |
| concepts[0].id | https://openalex.org/C2776040555 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7629403471946716 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q19903321 |
| concepts[0].display_name | Antimicrobial stewardship |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.753939688205719 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2426938 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6950153112411499 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[2].display_name | Medical prescription |
| concepts[3].id | https://openalex.org/C501593827 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6187914609909058 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[3].display_name | Antibiotics |
| concepts[4].id | https://openalex.org/C94665300 |
| concepts[4].level | 3 |
| concepts[4].score | 0.608254611492157 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q63391344 |
| concepts[4].display_name | Antibiotic resistance |
| concepts[5].id | https://openalex.org/C27415008 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5550383925437927 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7256382 |
| concepts[5].display_name | Psychological intervention |
| concepts[6].id | https://openalex.org/C99454951 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5092891454696655 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[6].display_name | Environmental health |
| concepts[7].id | https://openalex.org/C138816342 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4650946855545044 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q189603 |
| concepts[7].display_name | Public health |
| concepts[8].id | https://openalex.org/C512399662 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4498077630996704 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[8].display_name | Family medicine |
| concepts[9].id | https://openalex.org/C104863432 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4152306616306305 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q614304 |
| concepts[9].display_name | Pharmacy |
| concepts[10].id | https://openalex.org/C177713679 |
| concepts[10].level | 1 |
| concepts[10].score | 0.328737735748291 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[10].display_name | Intensive care medicine |
| concepts[11].id | https://openalex.org/C159110408 |
| concepts[11].level | 1 |
| concepts[11].score | 0.1441006064414978 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[11].display_name | Nursing |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C89423630 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[13].display_name | Microbiology |
| keywords[0].id | https://openalex.org/keywords/antimicrobial-stewardship |
| keywords[0].score | 0.7629403471946716 |
| keywords[0].display_name | Antimicrobial stewardship |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.753939688205719 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/medical-prescription |
| keywords[2].score | 0.6950153112411499 |
| keywords[2].display_name | Medical prescription |
| keywords[3].id | https://openalex.org/keywords/antibiotics |
| keywords[3].score | 0.6187914609909058 |
| keywords[3].display_name | Antibiotics |
| keywords[4].id | https://openalex.org/keywords/antibiotic-resistance |
| keywords[4].score | 0.608254611492157 |
| keywords[4].display_name | Antibiotic resistance |
| keywords[5].id | https://openalex.org/keywords/psychological-intervention |
| keywords[5].score | 0.5550383925437927 |
| keywords[5].display_name | Psychological intervention |
| keywords[6].id | https://openalex.org/keywords/environmental-health |
| keywords[6].score | 0.5092891454696655 |
| keywords[6].display_name | Environmental health |
| keywords[7].id | https://openalex.org/keywords/public-health |
| keywords[7].score | 0.4650946855545044 |
| keywords[7].display_name | Public health |
| keywords[8].id | https://openalex.org/keywords/family-medicine |
| keywords[8].score | 0.4498077630996704 |
| keywords[8].display_name | Family medicine |
| keywords[9].id | https://openalex.org/keywords/pharmacy |
| keywords[9].score | 0.4152306616306305 |
| keywords[9].display_name | Pharmacy |
| keywords[10].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[10].score | 0.328737735748291 |
| keywords[10].display_name | Intensive care medicine |
| keywords[11].id | https://openalex.org/keywords/nursing |
| keywords[11].score | 0.1441006064414978 |
| keywords[11].display_name | Nursing |
| language | en |
| locations[0].id | doi:10.3390/antibiotics11020199 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2736332253 |
| locations[0].source.issn | 2079-6382 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2079-6382 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Antibiotics |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Antibiotics |
| locations[0].landing_page_url | https://doi.org/10.3390/antibiotics11020199 |
| locations[1].id | pmid:35203802 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Antibiotics (Basel, Switzerland) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35203802 |
| locations[2].id | pmh:oai:doaj.org/article:3bb3487c75fd44a6ab36feffdf26da10 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Antibiotics, Vol 11, Iss 2, p 199 (2022) |
| locations[2].landing_page_url | https://doaj.org/article/3bb3487c75fd44a6ab36feffdf26da10 |
| locations[3].id | pmh:oai:mdpi.com:/2079-6382/11/2/199/ |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400947 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | True |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | MDPI (MDPI AG) |
| locations[3].source.host_organization | https://openalex.org/I4210097602 |
| locations[3].source.host_organization_name | Multidisciplinary Digital Publishing Institute (Switzerland) |
| locations[3].source.host_organization_lineage | https://openalex.org/I4210097602 |
| locations[3].license | cc-by |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Antibiotics; Volume 11; Issue 2; Pages: 199 |
| locations[3].landing_page_url | https://dx.doi.org/10.3390/antibiotics11020199 |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:8868487 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Antibiotics (Basel) |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8868487 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5021821422 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6141-9436 |
| authorships[0].author.display_name | Reuben Kiggundu |
| authorships[0].affiliations[0].raw_affiliation_string | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala P.O. Box 920102, Uganda |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Reuben Kiggundu |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala P.O. Box 920102, Uganda |
| authorships[1].author.id | https://openalex.org/A5068203048 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6606-8708 |
| authorships[1].author.display_name | Rachel Wittenauer |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I201448701 |
| authorships[1].affiliations[0].raw_affiliation_string | School of Pharmacy, University of Washington, Seattle, WA 98105, USA |
| authorships[1].institutions[0].id | https://openalex.org/I201448701 |
| authorships[1].institutions[0].ror | https://ror.org/00cvxb145 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I201448701 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Washington |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Rachel Wittenauer |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | School of Pharmacy, University of Washington, Seattle, WA 98105, USA |
| authorships[2].author.id | https://openalex.org/A5042305683 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9612-1840 |
| authorships[2].author.display_name | JP Waswa |
| authorships[2].affiliations[0].raw_affiliation_string | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala P.O. Box 920102, Uganda |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | JP Waswa |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala P.O. Box 920102, Uganda |
| authorships[3].author.id | https://openalex.org/A5066155756 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Hilma Nakambale |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I201448701 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Global Health, University of Washington, Seattle, WA 98105, USA |
| authorships[3].institutions[0].id | https://openalex.org/I201448701 |
| authorships[3].institutions[0].ror | https://ror.org/00cvxb145 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I201448701 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of Washington |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hilma N. Nakambale |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Global Health, University of Washington, Seattle, WA 98105, USA |
| authorships[4].author.id | https://openalex.org/A5070817307 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2277-9572 |
| authorships[4].author.display_name | Freddy Eric Kitutu |
| authorships[4].countries | UG |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I72227227 |
| authorships[4].affiliations[0].raw_affiliation_string | Sustainable Pharmaceutical Systems (SPS) Unit, Pharmacy Department, Makerere University School of Health Sciences, Kampala P.O. Box 10217, Uganda |
| authorships[4].institutions[0].id | https://openalex.org/I72227227 |
| authorships[4].institutions[0].ror | https://ror.org/03dmz0111 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I72227227 |
| authorships[4].institutions[0].country_code | UG |
| authorships[4].institutions[0].display_name | Makerere University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Freddy Eric Kitutu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Sustainable Pharmaceutical Systems (SPS) Unit, Pharmacy Department, Makerere University School of Health Sciences, Kampala P.O. Box 10217, Uganda |
| authorships[5].author.id | https://openalex.org/A5025392162 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0246-0249 |
| authorships[5].author.display_name | Marion Murungi |
| authorships[5].affiliations[0].raw_affiliation_string | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala P.O. Box 920102, Uganda |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Marion Murungi |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala P.O. Box 920102, Uganda |
| authorships[6].author.id | https://openalex.org/A5035518590 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Neville Okuna |
| authorships[6].countries | UG |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210092895 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pharmaceuticals and Natural Medicines, Ministry of Health, Kampala P.O. Box 7272, Uganda |
| authorships[6].institutions[0].id | https://openalex.org/I4210092895 |
| authorships[6].institutions[0].ror | https://ror.org/00hy3gq97 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210092895 |
| authorships[6].institutions[0].country_code | UG |
| authorships[6].institutions[0].display_name | Ministry of Health |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Neville Okuna |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Pharmaceuticals and Natural Medicines, Ministry of Health, Kampala P.O. Box 7272, Uganda |
| authorships[7].author.id | https://openalex.org/A5087729172 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Morries Seru |
| authorships[7].countries | UG |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210092895 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Pharmaceuticals and Natural Medicines, Ministry of Health, Kampala P.O. Box 7272, Uganda |
| authorships[7].institutions[0].id | https://openalex.org/I4210092895 |
| authorships[7].institutions[0].ror | https://ror.org/00hy3gq97 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210092895 |
| authorships[7].institutions[0].country_code | UG |
| authorships[7].institutions[0].display_name | Ministry of Health |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Seru Morries |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Pharmaceuticals and Natural Medicines, Ministry of Health, Kampala P.O. Box 7272, Uganda |
| authorships[8].author.id | https://openalex.org/A5085268010 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-8229-8768 |
| authorships[8].author.display_name | Lynn Lieberman Lawry |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210140673 |
| authorships[8].affiliations[0].raw_affiliation_string | Overseas Strategic Consulting, Ltd., Philadelphia, PA 19102, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210140673 |
| authorships[8].institutions[0].ror | https://ror.org/04mptne15 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210140673 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Strategic Solutions Consulting (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Lynn Lieberman Lawry |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Overseas Strategic Consulting, Ltd., Philadelphia, PA 19102, USA |
| authorships[9].author.id | https://openalex.org/A5080480392 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4846-6312 |
| authorships[9].author.display_name | Mohan P. Joshi |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210099762 |
| authorships[9].affiliations[0].raw_affiliation_string | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA |
| authorships[9].institutions[0].id | https://openalex.org/I4210099762 |
| authorships[9].institutions[0].ror | https://ror.org/00wf4pt88 |
| authorships[9].institutions[0].type | nonprofit |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210099762 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Management Sciences for Health |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Mohan P. Joshi |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA |
| authorships[10].author.id | https://openalex.org/A5090839379 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0057-6627 |
| authorships[10].author.display_name | Andy Stergachis |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I201448701 |
| authorships[10].affiliations[0].raw_affiliation_string | School of Pharmacy, University of Washington, Seattle, WA 98105, USA |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I201448701 |
| authorships[10].affiliations[1].raw_affiliation_string | Department of Global Health, University of Washington, Seattle, WA 98105, USA |
| authorships[10].institutions[0].id | https://openalex.org/I201448701 |
| authorships[10].institutions[0].ror | https://ror.org/00cvxb145 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I201448701 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | University of Washington |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Andy Stergachis |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Global Health, University of Washington, Seattle, WA 98105, USA, School of Pharmacy, University of Washington, Seattle, WA 98105, USA |
| authorships[11].author.id | https://openalex.org/A5021621358 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-6828-1182 |
| authorships[11].author.display_name | Niranjan Konduri |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210099762 |
| authorships[11].affiliations[0].raw_affiliation_string | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA |
| authorships[11].institutions[0].id | https://openalex.org/I4210099762 |
| authorships[11].institutions[0].ror | https://ror.org/00wf4pt88 |
| authorships[11].institutions[0].type | nonprofit |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210099762 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Management Sciences for Health |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Niranjan Konduri |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10897 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2402 |
| primary_topic.subfield.display_name | Applied Microbiology and Biotechnology |
| primary_topic.display_name | Antibiotic Use and Resistance |
| related_works | https://openalex.org/W2367483416, https://openalex.org/W2955020749, https://openalex.org/W2507683919, https://openalex.org/W2029063045, https://openalex.org/W2076505260, https://openalex.org/W4226193097, https://openalex.org/W4320037900, https://openalex.org/W4297123388, https://openalex.org/W3032187068, https://openalex.org/W4221083638 |
| cited_by_count | 72 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 15 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 28 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 20 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 9 |
| locations_count | 5 |
| best_oa_location.id | doi:10.3390/antibiotics11020199 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2736332253 |
| best_oa_location.source.issn | 2079-6382 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2079-6382 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Antibiotics |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Antibiotics |
| best_oa_location.landing_page_url | https://doi.org/10.3390/antibiotics11020199 |
| primary_location.id | doi:10.3390/antibiotics11020199 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2736332253 |
| primary_location.source.issn | 2079-6382 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2079-6382 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Antibiotics |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/2079-6382/11/2/199/pdf?version=1643958688 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Antibiotics |
| primary_location.landing_page_url | https://doi.org/10.3390/antibiotics11020199 |
| publication_date | 2022-02-04 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2806428847, https://openalex.org/W2805164387, https://openalex.org/W2969465689, https://openalex.org/W3039269339, https://openalex.org/W3105850549, https://openalex.org/W3135046788, https://openalex.org/W3151080094, https://openalex.org/W2765794983, https://openalex.org/W2515936323, https://openalex.org/W2921225068, https://openalex.org/W2888993305, https://openalex.org/W2774930500, https://openalex.org/W2017331060, https://openalex.org/W3169751830, https://openalex.org/W3009130625, https://openalex.org/W2950259053, https://openalex.org/W2938372816, https://openalex.org/W3173571830, https://openalex.org/W2729893349, https://openalex.org/W3011122532, https://openalex.org/W2798042179, https://openalex.org/W2953857662, https://openalex.org/W3128338482, https://openalex.org/W3124894769, https://openalex.org/W3143871140, https://openalex.org/W3047668176, https://openalex.org/W3083749175, https://openalex.org/W3200137608, https://openalex.org/W2987928905, https://openalex.org/W2901487345, https://openalex.org/W3005046185, https://openalex.org/W3057302762, https://openalex.org/W2045227512, https://openalex.org/W3046910414, https://openalex.org/W3139380820, https://openalex.org/W2917124028, https://openalex.org/W3044767989, https://openalex.org/W3119709038, https://openalex.org/W3112487752, https://openalex.org/W3111441668, https://openalex.org/W3137046415, https://openalex.org/W2991491647, https://openalex.org/W3134973183, https://openalex.org/W2182489077, https://openalex.org/W2921471402, https://openalex.org/W2135246614, https://openalex.org/W3128498352, https://openalex.org/W2237972339, https://openalex.org/W3114134536, https://openalex.org/W3123235992, https://openalex.org/W3164469338, https://openalex.org/W3203686298, https://openalex.org/W3173982327, https://openalex.org/W2613969664, https://openalex.org/W2971783535, https://openalex.org/W2903476979 |
| referenced_works_count | 56 |
| abstract_inverted_index.a | 139 |
| abstract_inverted_index.13 | 53 |
| abstract_inverted_index.To | 18 |
| abstract_inverted_index.by | 147 |
| abstract_inverted_index.in | 13, 26, 28, 52, 177 |
| abstract_inverted_index.of | 2, 9, 83, 89, 92, 118, 143, 151, 161, 165, 174 |
| abstract_inverted_index.on | 121 |
| abstract_inverted_index.or | 123 |
| abstract_inverted_index.to | 30, 48, 79, 94, 105, 138 |
| abstract_inverted_index.74% | 117 |
| abstract_inverted_index.The | 163 |
| abstract_inverted_index.WHO | 107 |
| abstract_inverted_index.and | 55, 66, 74, 77, 86, 101, 110, 179 |
| abstract_inverted_index.are | 180 |
| abstract_inverted_index.few | 20 |
| abstract_inverted_index.for | 63, 171, 183 |
| abstract_inverted_index.key | 169 |
| abstract_inverted_index.low | 132 |
| abstract_inverted_index.one | 122 |
| abstract_inverted_index.the | 6, 39, 60, 81, 87, 90, 106, 148, 155, 172 |
| abstract_inverted_index.use | 4, 25, 51, 85, 150 |
| abstract_inverted_index.was | 131, 154 |
| abstract_inverted_index.(37% | 160 |
| abstract_inverted_index.(44% | 142 |
| abstract_inverted_index.1077 | 64 |
| abstract_inverted_index.1387 | 67 |
| abstract_inverted_index.2020 | 73 |
| abstract_inverted_index.2021 | 76 |
| abstract_inverted_index.Data | 62 |
| abstract_inverted_index.This | 36, 113 |
| abstract_inverted_index.gaps | 32 |
| abstract_inverted_index.have | 22 |
| abstract_inverted_index.high | 140 |
| abstract_inverted_index.more | 124 |
| abstract_inverted_index.most | 156 |
| abstract_inverted_index.that | 33, 116 |
| abstract_inverted_index.this | 166 |
| abstract_inverted_index.used | 137, 158 |
| abstract_inverted_index.were | 69, 120, 136 |
| abstract_inverted_index.wide | 149 |
| abstract_inverted_index.with | 97, 127 |
| abstract_inverted_index.April | 75 |
| abstract_inverted_index.World | 40 |
| abstract_inverted_index.areas | 170 |
| abstract_inverted_index.date, | 19 |
| abstract_inverted_index.found | 115 |
| abstract_inverted_index.point | 44 |
| abstract_inverted_index.study | 37, 114, 167 |
| abstract_inverted_index.types | 91 |
| abstract_inverted_index.which | 153 |
| abstract_inverted_index.(30%); | 133 |
| abstract_inverted_index.(AMR). | 17 |
| abstract_inverted_index.Health | 41 |
| abstract_inverted_index.Uganda | 29, 98, 128, 178 |
| abstract_inverted_index.Watch, | 109 |
| abstract_inverted_index.across | 59 |
| abstract_inverted_index.assess | 49, 95 |
| abstract_inverted_index.degree | 141 |
| abstract_inverted_index.driven | 146 |
| abstract_inverted_index.future | 184 |
| abstract_inverted_index.mainly | 145 |
| abstract_inverted_index.public | 54 |
| abstract_inverted_index.survey | 46 |
| abstract_inverted_index.Access, | 108 |
| abstract_inverted_index.Reserve | 111 |
| abstract_inverted_index.applied | 38 |
| abstract_inverted_index.between | 71 |
| abstract_inverted_index.private | 56 |
| abstract_inverted_index.require | 34 |
| abstract_inverted_index.results | 164 |
| abstract_inverted_index.studies | 21 |
| abstract_inverted_index.Clinical | 99, 129 |
| abstract_inverted_index.December | 72 |
| abstract_inverted_index.analyzed | 78 |
| abstract_inverted_index.assessed | 23 |
| abstract_inverted_index.classify | 102 |
| abstract_inverted_index.country. | 61 |
| abstract_inverted_index.identify | 31, 168 |
| abstract_inverted_index.patients | 65, 119 |
| abstract_inverted_index.according | 104 |
| abstract_inverted_index.collected | 70 |
| abstract_inverted_index.effective | 7 |
| abstract_inverted_index.hospitals | 27, 58 |
| abstract_inverted_index.important | 181 |
| abstract_inverted_index.underpins | 5 |
| abstract_inverted_index.Compliance | 126 |
| abstract_inverted_index.Guidelines | 130 |
| abstract_inverted_index.antibiotic | 3, 24, 50, 84, 159 |
| abstract_inverted_index.benchmarks | 182 |
| abstract_inverted_index.combatting | 14 |
| abstract_inverted_index.compliance | 96 |
| abstract_inverted_index.frequently | 157 |
| abstract_inverted_index.monitoring | 1 |
| abstract_inverted_index.prevalence | 45, 88 |
| abstract_inverted_index.resistance | 16 |
| abstract_inverted_index.understand | 80 |
| abstract_inverted_index.Guidelines; | 100 |
| abstract_inverted_index.antibiotics | 93, 103, 135 |
| abstract_inverted_index.improvement | 173 |
| abstract_inverted_index.methodology | 47 |
| abstract_inverted_index.stewardship | 11, 176 |
| abstract_inverted_index.Standardized | 0 |
| abstract_inverted_index.antibiotics. | 125 |
| abstract_inverted_index.ceftriaxone, | 152 |
| abstract_inverted_index.evaluations. | 185 |
| abstract_inverted_index.standardized | 43 |
| abstract_inverted_index.antimicrobial | 10, 15, 175 |
| abstract_inverted_index.intervention. | 35 |
| abstract_inverted_index.interventions | 12 |
| abstract_inverted_index.prescriptions | 68 |
| abstract_inverted_index.implementation | 8 |
| abstract_inverted_index.not-for-profit | 57 |
| abstract_inverted_index.characteristics | 82 |
| abstract_inverted_index.classification. | 112 |
| abstract_inverted_index.prescriptions), | 144 |
| abstract_inverted_index.prescriptions). | 162 |
| abstract_inverted_index.Organization’s | 42 |
| abstract_inverted_index.Watch-classified | 134 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| corresponding_author_ids | https://openalex.org/A5021821422 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/17 |
| sustainable_development_goals[0].score | 0.4000000059604645 |
| sustainable_development_goals[0].display_name | Partnerships for the goals |
| citation_normalized_percentile.value | 0.98931878 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |